| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/25/2004 | WO2004024189A1 Stable immunogenic product comprising antigenic heterocomplexes |
| 03/25/2004 | WO2004024182A2 Method for isolating hepatitis c virus peptides |
| 03/25/2004 | WO2004024180A1 Lactoferrin compositions and methods of wound treatment |
| 03/25/2004 | WO2004024179A1 Methods for treating lung cancer using insulin-like growth factorbinding protein-3 |
| 03/25/2004 | WO2004024178A1 Cxcr4 receptor antagonists |
| 03/25/2004 | WO2004024177A1 Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein |
| 03/25/2004 | WO2004024176A1 Synergistic combination of silk proteins |
| 03/25/2004 | WO2004024174A1 Method and composition for regulating the activity of regulatory t cells |
| 03/25/2004 | WO2004024173A2 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 03/25/2004 | WO2004024171A1 Chronic lymphocytic leukemia combination treatment (treated cll cells and cytokine) |
| 03/25/2004 | WO2004024169A1 Composition comprising an abrasive agent for treating insect bites |
| 03/25/2004 | WO2004024151A1 Composition and potentiating method |
| 03/25/2004 | WO2004024125A1 Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same |
| 03/25/2004 | WO2004024097A2 Compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024095A2 ß-L-2'-DEOXYNUCLEOSIDES FOR THE TREATMENT OF RESISTANT HBV STRAINS AND COMBINATION THERAPIES |
| 03/25/2004 | WO2004024092A2 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 03/25/2004 | WO2004024088A2 Design of chemokine analogs for the treatment of human diseases |
| 03/25/2004 | WO2004024077A2 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | WO2004024076A2 Novel compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024075A2 Chemokine receptor antagonists as therapeutic agents |
| 03/25/2004 | WO2004024072A2 Novel compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024064A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004024063A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004023869A1 Use of plag or plag-inhibitors to diagnose and/or treat disease |
| 03/25/2004 | WO2004014367A3 Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer's disease |
| 03/25/2004 | WO2004013319A3 Regulation of human esterase |
| 03/25/2004 | WO2004007719A8 Use of sumo- and ubiquitin-modified pcna for detection and channeling of dna transaction pathways |
| 03/25/2004 | WO2004007718A3 Rna-interference by single-stranded rna molecules |
| 03/25/2004 | WO2004006954A3 Transdermal botulinum toxin compositions |
| 03/25/2004 | WO2004005346A8 Human nuclear hormone receptor |
| 03/25/2004 | WO2004005324A3 Peptide composition for treatment of sexual dysfunction |
| 03/25/2004 | WO2004004665A3 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 03/25/2004 | WO2004003011A3 Nuclear hormone receptor |
| 03/25/2004 | WO2004000289A3 Preparations for the intranasal application of selected cgrp antagonists derived from amino acids and a method for their production |
| 03/25/2004 | WO2003107008A3 DIAGNOSTIC POLYMORPHISM OF 11ß-HYDROXYSTEROID DEHYDROGENASE USEFUL FOR IDENTIFYING RISK OF DEVELOPING ALZHEIMER'S DISEASE |
| 03/25/2004 | WO2003100059A3 Molecular targeting of the igf-1 receptor |
| 03/25/2004 | WO2003100001A3 Claudin polypeptides, polynucleotides, and methods of making and use thereof |
| 03/25/2004 | WO2003097677A3 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus |
| 03/25/2004 | WO2003093485A3 Optimization of transgene expression in mammalian cells |
| 03/25/2004 | WO2003093314A3 Connective tissue stimulating peptides |
| 03/25/2004 | WO2003092735A3 Peptide nucleic acid conjugates with beta-amino acid polymers or reptoids |
| 03/25/2004 | WO2003092624A3 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 03/25/2004 | WO2003092610A3 Methods of using cytokine antagonists to treat hiv infection and aids |
| 03/25/2004 | WO2003090685A3 Methods for stimulating tlr/irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses |
| 03/25/2004 | WO2003087154A3 Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments |
| 03/25/2004 | WO2003087069A3 Dipeptidic growth hormone secretagogues |
| 03/25/2004 | WO2003087050A3 Novel perindopril salt and pharmaceutical compositions containing same |
| 03/25/2004 | WO2003086326A3 G-type peptides to ameliorate atherosclerosis |
| 03/25/2004 | WO2003084565A3 Ve-ptp as regulator of ve-cadherin mediated processes or disorders |
| 03/25/2004 | WO2003082908A3 Use of the p17 protein of hiv in isolated form for the preparation of a medicament for administration to hiv seropositive patients, as well as pharmaceutical compositions comprising said protein |
| 03/25/2004 | WO2003082902A3 Novel corticotropin-releasing hormone analogs |
| 03/25/2004 | WO2003080098A3 Diagnostics and therapeutics for diseases associated with homo sapiens formyl peptide receptor-like 2 |
| 03/25/2004 | WO2003077949A3 Methods of treating diabetes using pde 11a inhibitors |
| 03/25/2004 | WO2003075903A3 Use proline and its functional equivalentsfor quenching ros and/ or radicals |
| 03/25/2004 | WO2003075746A3 Methods for aneurysm repair |
| 03/25/2004 | WO2003075741A9 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 03/25/2004 | WO2003072528A3 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 03/25/2004 | WO2003072195A3 Method for administering glp-1 molecules |
| 03/25/2004 | WO2003072060A3 Polypeptide formulation |
| 03/25/2004 | WO2003070884A3 RNA INTERFERENCE MEDIATED INHIBITION OF MDR P-GLYCOPROTEIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/25/2004 | WO2003068944A3 METHODS AND COMPOSITION FOR MODULATING TYPE I MUSCLE FORMATION USING PGC-1α- |
| 03/25/2004 | WO2003066104A3 Pharmaceutical composition which improves in vivo gene transfer |
| 03/25/2004 | WO2003064458A3 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof |
| 03/25/2004 | WO2003061592A3 Methods for therapeutic treatment of benign prostatic hypertrophy (bph) |
| 03/25/2004 | WO2003059374A3 Use of dimer-specific nuclear localisation signal peptides (dsnls) derived from the stat dna binding domain |
| 03/25/2004 | WO2003059372A3 Combined use of a glp-1 compound and a modulator of diabetic late complications |
| 03/25/2004 | WO2003057721A3 Substituted amino carboxamides for the treatment of alzheimer's disease |
| 03/25/2004 | WO2003055443A3 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 03/25/2004 | WO2003054156A3 Novel g proein-coupled receptor, gave7 |
| 03/25/2004 | WO2003052134A3 Oligonucleotides comprising intercalator pseudonucleotide(s) for detection of nucleic acids and mutants hereof |
| 03/25/2004 | WO2003051923A3 Novel g-protein coupled receptors and dna sequences thereof |
| 03/25/2004 | WO2003048195A3 Glucose dependant release of insulin from glucose sensing insulin derivatives |
| 03/25/2004 | WO2003046578A3 Method for the assessment and prognosis of sarcoidosis |
| 03/25/2004 | WO2003040296A3 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 03/25/2004 | WO2003039475A3 Methods of identifying and using modulators of fractalkine receptor |
| 03/25/2004 | WO2003037361A3 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 03/25/2004 | WO2003033680A3 Kinases and phosphatases |
| 03/25/2004 | WO2003033659A3 Antisense modulation of matrix metalloproteinase 1 expression |
| 03/25/2004 | WO2003031472A3 Insulin mimetic amino acid sequences |
| 03/25/2004 | WO2003028633A3 Parenteral delivery systems |
| 03/25/2004 | WO2003027081A3 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 03/25/2004 | WO2003020749A3 Ncam binding compounds |
| 03/25/2004 | WO2003020215A3 Methods of treating mycocardial event related coditions with thymosin beta 4 |
| 03/25/2004 | WO2003016351A3 N - cam related compounds modulating cell groth |
| 03/25/2004 | WO2003015812A3 Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/25/2004 | WO2003015612A3 Materials and methods to promote repair of nerve tissue |
| 03/25/2004 | WO2003014301A3 Hprp4s as modifiers of the p53 pathway and methods of use |
| 03/25/2004 | WO2003012122A8 Crystallized structure of type iv collagen nc1 domain hexamer |
| 03/25/2004 | WO2003006501A3 G-csf conjugates |
| 03/25/2004 | WO2003004618A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/25/2004 | WO2003000901A3 Nucleic acids encoding protein kinases |
| 03/25/2004 | WO2002102993A3 Human secreted proteins |
| 03/25/2004 | WO2002102399A3 Mucosal repair by tff2 peptides |
| 03/25/2004 | WO2002098455A3 Production of recombinant human arylsulfatase a |
| 03/25/2004 | WO2002096942A3 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof |
| 03/25/2004 | WO2002089832A3 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 03/25/2004 | WO2002085093A3 Replikin peptides and uses thereof |
| 03/25/2004 | WO2002076394A3 Enzyme-based anti-cancer compositions and methods |
| 03/25/2004 | WO2002074048A3 P-glycoproteins and uses thereof |
| 03/25/2004 | WO2002066044A3 Method for dendritic cells based immunotherapy of tumors using combination therapy |